| Filed On | Filing |
|---|---|
| 28 Jan 2026 |
Form 3: Tcg Crossover Gp II, Llc, 10% owner and 3 others
Holds 637,005 shares of Common Stock |
| 13 Nov 2025 |
Form 3: Maleki Andrew Pedrum, Chief Financial Officer
No securities owned |
| 28 Mar 2025 |
Form 3: Kutzkey Tim, Director
Holds 704,332 shares of Common Stock |
| 23 Aug 2023 |
Form 3: Li Yang, Exec. Vice President, Research
Holds 121,524 shares of Common Stock |
| 05 Apr 2023 | Form 3: Bjerkholt Eric, Director |
| 16 Aug 2021 |
Form 3: Column Group Iii GP, Lp, 10% owner and 2 others
Holds 4,343,245 shares of Common Stock |
| 16 Aug 2021 |
Form 3: Kutzkey Tim, Director
Holds 4,343,245 shares of Common Stock |
| 16 Aug 2021 | Form 3: Parker Craig C, Director |
| 16 Aug 2021 |
Form 3: Vanhove Geertrui, Chief Medical Officer
Holds 22,834 shares of Common Stock |
| 16 Aug 2021 | Form 3: Williams Charles O, Chief Financial Officer |
| 16 Aug 2021 |
Form 3: Woodhouse David J, Director
Holds 35,129 shares of Common Stock |
| 16 Aug 2021 |
Form 3: Rothenberg Mace, Director
Holds 35,129 shares of Common Stock |
| 16 Aug 2021 |
Form 3: Lin Shao-Lee, Director
Holds 35,129 shares of Common Stock |
| 16 Aug 2021 |
Form 3: Haak-Frendscho Mary, Director
Holds 35,129 shares of Common Stock |
| 16 Aug 2021 |
Form 3: Chai Christopher Y, Director
Holds 35,129 shares of Common Stock |
| 16 Aug 2021 |
Form 3: Berkenblit Anna, Director
Holds 35,129 shares of Common Stock |
| 16 Aug 2021 |
Form 3: Yeh Wen-Chen, Chief Scientific Officer
Holds 219,560 shares of Common Stock |
| 04 Dec 2020 |
Form 3: Consonance Capital Management Lp, Director and 2 others
No securities owned |
| 18 Nov 2020 |
Form 3: Soffer Gad, Director
No securities owned |
| 18 Nov 2020 | Form 3: Santel Donald J, Director |
Loading...